Skip to main content

Table 8 Summary of “other” conditions each representing less than 1.0% of the total sample of patients seeking medical cannabis certification

From: Medical cannabis use in the United States: a retrospective database study

Condition

Patients, n (%)

n = 6519

Neuropathic Pain

580 (0.9%)

Spinal Cord Injury/Disease

574 (0.9%)

Glaucoma

480 (0.8%)

Crohn’s Disease

472 (0.8%)

Stress

418 (0.7%)

Multiple Sclerosis

396 (0.6%)

Irritable Bowel Syndrome

364 (0.6%)

Mood Disorders

271 (0.4%)

Acute Pain

253 (0.4%)

Colitis

244 (0.4%)

HIV/AIDS

224 (0.4%)

Opiate Dependence

183 (0.3%)

Scoliosis

156 (0.3%)

Appetite Stimulation

152 (0.2%)

Parkinson’s Disease Symptoms

148 (0.2%)

Hepatitis C

133 (0.2%)

Chemotherapy Induced Nausea

108 (0.2%)

Autism

57 (0.1%)

Cachexia/Wasting Syndrome

56 (0.1%)

Movement Disorder

46 (0.1%)

Anorexia

42 (0.1%)

Obsessive Compulsive Behaviour

41 (0.1%)

Tremors

38 (0.1%)

Alzheimer’s Disease

26 (0.0%)

Bipolar Disorder

25 (0.0%)

Tourette’s Syndrome

10 (0.0%)

Other

1022 (2.0%)

  1. Table 8 reports the “other” conditions reported in Table 5 that each represent less than 1.0% of the total sample. Percentages are given out of the total sample (61,379 patients). There are over 200 unique conditions that were manually entered into the database by clinic staff that are categorized as “Other” in this Table. HIV human immunodeficiency viruses, AIDS acquired immunodeficiency syndrome